Article Text
Abstract
Introduction Percutaneous aortic valve replacement (transcatheter aortic valve implantation (TAVI)) notably increases the likelihood of the appearance of a complete left bundle branch block (LBBB) by direct lesion of the LBB of His. This block can lead to high-grade atrioventricular conduction disturbances responsible for a poorer prognosis. The management of this complication remains controversial.
Method and analysis The screening of LBBB after TAVI persisting for more than 24 hours will be conducted by surface ECG. Stratification will be performed by post-TAVI intracardiac electrophysiological study. Patients at high risk of conduction disturbances (≥70 ms His–ventricle interval (HV) or presence of infra-Hisian block) will be implanted with a pacemaker enabling the recording of disturbance episodes. Those at lower risk (HV <70 ms) will be implanted with a loop recorder device with remote monitoring of cardiovascular implantable electronic devices (CIEDs). Clinical, ECG and implanted device follow-up will also be performed at 3, 6 and 12 months. The primary objective is to assess the efficacy and safety of a decisional algorithm based on electrophysiological study and remote monitoring of CIEDs in the prediction of high-grade conduction disturbances in patients with LBBB after TAVI. The primary end point is to compare the incidence (rate and time to onset) of high-grade conduction disturbances in patients with LBBB after TAVI between the two groups at 12 months. Given the proportion of high-grade conduction disturbances (20–40%), a sample of 200 subjects will allow a margin of error of 6–7%. The LBBB–TAVI Study has been in an active recruiting phase since September 2015 (21 patients already included).
Ethics and dissemination Local ethics committee authorisation was obtained in May 2015. We will publish findings from this study in a peer-reviewed scientific journal and present results at national and international conferences.
Trial registration number NCT02482844; Pre-results.
- Left bundle branch block
- remote monitoring.
- Transcatheter aortic valve implantation
- cardiac electrophysiology
This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Statistics from Altmetric.com
Footnotes
Contributors GM, FJ, GS, BP and RE contributed to the conception of the study. All authors contributed to the study design. The manuscript protocol was drafted by GM, BP, PB and RE. Screening of studies for inclusion will be undertaken by all authors (clinician) except BP (methodologist). Data extraction will be undertaken by GM, BP and RE. All authors approved the publication of the protocol.
Funding This clinical trial is funded with the support of Biotronik and the Sorin Group. However, the authors are solely responsible for the design and conduct of this study as well as all study analyses and the drafting and editing of the article.
Competing interests None declared.
Patient consent Obtained.
Ethics approval Local ethics committee (CPP Sud Est VI, AU1181).
Provenance and peer review Not commissioned; externally peer reviewed.